SARS, Malaria, and the Microarray

It was the first Saturday of Spring 2003, and Joe DeRisi and his postdoc David Wang were staked out at either end of the University of California, San Francisco's Genentech Hall waiting for the FedEx truck.

Written byKaren Hopkin
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Photo: Felix Aburto

It was the first Saturday of Spring 2003, and Joe DeRisi and his postdoc David Wang were staked out at either end of the University of California, San Francisco's Genentech Hall waiting for the FedEx truck. DeRisi, had recently moved his lab to the university's new Mission Bay campus. With the lot still surrounded by chain link fencing and the loading dock closed for the weekend, DeRisi and Wang feared that the FedEx driver might get discouraged and depart without delivering their package: samples of genetic material extracted from the causative agent of SARS.

At the time, SARS was killing patients and healthcare workers in Southeast Asia. Diagnostic tests had until that point failed to identify the culprit. DeRisi thought he could help. Over the previous year, DeRisi, Wang, HHMI investigator Don Ganem, and their UCSF colleagues had engineered a microarray that sported sequences from all known ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies